Dr. Shokry has been with Ross University School of Veterinary Medicine since 1989. In addition to his teaching responsibilities, Dr. Shokry advises the student Integrative Veterinary Medicine Club (IVMC).
He completed a post-doctoral research fellowship with the Department of Pharmacology, Guy’s Hospital Medical School in London, U.K. In addition, he was a visiting scientist at Iowa State University, College of Veterinary Medicine, and has been appointed as a research affiliate professor at Charles E. Schmidt College of Medicine, FAU in Florida.
- Shokry, I. M., J. J. Callanan, J. Sousa and R. Tao, 2016: New Insights on Different Response of MDMA-Elicited Serotonin Syndrome to Systemic and Intracranial Administrations in the Rat Brain. PloS one, 11, e0155551.
- Shokry, I. M., A. Maqueira, J. J. Callanan, C. Shields, C. Clayton and R. Tao, 2016: Effects of synthetic cathinones ('bath salts') on rat behavior. European Neuropsychopharmacology, 26, S230.
- Tao R, Shokry IM, Callanan JJ. Environment underlying Ecstasy-induced serotonin syndrome. Annals of Forensic Research and Analysis. 4(1): 1039, 2017
- Shokry I.M., Callanan, J.J., Tao, R. (2017). D1 receptors, but not D2, mediate the locomotor activity and behavioral sensitization caused by 3,4-methylenedioxypyrovalerone (MDPV) in rats. European Neuropsychopharmacology, 27(Supplement 4), Page S642.
- Shokry, I., DeSuza, K, Callanan, J, Shim, G, Ma, Z, Tao, R. (2018). Individuals with Hyperthyroidism are More Susceptible to having a Serious Serotonin Syndrome Following MDMA (Ecstasy) Administration in Rats Ann Forensic Res Anal.
- Shokry, I. M., Callanan, J. J., & Tao, R. (2019). Cortical dopamine is essential for the hallucinogenic effect of 3,4-methylenedioxypyrovalerone (MDPV) demonstrated by enhanced EEG activity in rats. European Neuropsychopharmacology, 29, S98-S99. doi:https://doi.org/10.1016/j.euroneuro.2018.11.1084
- Shokry, I. M., Sinha, V., Da Silva, G., Park, S. B., Callanan, J. J., & Tao, R. (2019). Comparison of electroencephalogram (EEG) response to MDPV versus the hallucinogenic drugs MK-801 and ketamine in rats. Exp Neurol, 313, 26-36. doi:10.1016/j.expneurol.2018.12.001